Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Key Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Menu
Professors
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Philip J. Kranzusch, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Paul C. Adamson, MD, MPH
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Paul E. Turner, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Paul L. Bollyky, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Peter Reiss, MD, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Peter L. Anderson, PharmD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Paul Goepfert, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Philip J. Bolduc, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Penny Moore, PhD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Peter Chin-Hong, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Patrick G. Yeni, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Paul E. Sax, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Priscilla Y. Hsue, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Peter C. Cassat, JD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Paul A. Volberding, MD
University of California San Francisco
Professor of Medicine, Emeritus
San Francisco, CA
Page 31 of 34
« First
«
...
10
20
...
29
30
31
32
33
...
»
Last »
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Key Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
FAQs
Practice Question of the Week
February 17, 2025: COVID-19 Reinfection in People With Multiple Vaccinations and Chronic Conditions
A 68-year-old man who has been vaccinated 4 times with the mRNA COVID-19 vaccine comes down with his third episode of COVID-19 disease. His most recent vaccination was 6 months ago. His underlying medical conditions include hypertension, hyperlipidemia, and type 2 diabetes mellitus. Which of the following is true regarding this current episode of COVID-19 disease?
A. His risk of hospitalization from this episode is higher than someone who has only received 3 prior COVID-19 vaccinations, but no prior COVID-19 disease
B. His humoral immunity is more robust than his cellular immunity at the time of exposure to SARS-CoV-2 infection that led to the current infection (6 months after his last vaccination)
C. His symptom burden during this infection will be about the same as a person with similar health conditions who has had COVID-19 disease in the past but has never received a COVID-19 vaccine
D. His risk of developing long COVID increases with each episode of COVID-19 disease
Listen to the Podcast
View Archived Questions
Leave Feedback
Subscribe
CLOSE